Lloyd Diamond interviewed by Laurent Grassin on Boursorama

The Biotech Journal interview is dedicated to Lloyd Diamond, the CEO of Pixium Vision. He discusses the progress of the PRIMAvera pivotal study for the Prima device in dry AMD, the results of which are expected by the end of this year. He also explains the reasons behind the strengthening of the medtech’s board of directors and comments on recent stock price developments.